Skip to content

Next Milestone Ventures

Screen Shot 2019-07-18 at 1.18.49 PM

Hemogenyx Pharmaceuticals

HemoGenyx is a pre-clinical stage biopharmaceutical group developing new medicines and treatments to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases.

 

Team:

Dr. Vladislav Sandler, Co-founder, and CEO

Alexis Sandler, Co-founder, and non-executive director

Newsletter Signup

Next Milestone is a Program of